These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18268938)

  • 41. Impact of Birth Weight and Smoking on Lung Function in Patients with Asthma, COPD, and Healthy Volunteers.
    Panaszek B; Pawłowicz R; Lindner K; Dobek R; Panaszek K; Obojski A; Rosińczuk J; Ichnowski J
    Adv Clin Exp Med; 2016; 25(6):1207-1213. PubMed ID: 28028975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.
    Xiao T; Wijnant SRA; Licher S; Terzikhan N; Lahousse L; Ikram MK; Brusselle GG; Ikram MA
    J Alzheimers Dis; 2021; 82(2):621-630. PubMed ID: 34057085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV
    Wang Y; Liao J; Zhong Y; Zhang C; Li X; Wang G
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2825-2833. PubMed ID: 31824147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between airway obstruction and C-reactive protein levels in a community-based population of Korea.
    Yoo B; Lee SH; Kim SY; Leem AY; Chung KS; Kim EY; Jung JY; Kang YA; Park MS; Chang J; Kim YS; Park Y
    Int J Tuberc Lung Dis; 2019 Nov; 23(11):1228-1234. PubMed ID: 31718761
    [No Abstract]   [Full Text] [Related]  

  • 46. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
    Abramson MJ; Kaushik S; Benke GP; Borg BM; Smith CL; Dharmage SC; Thompson BR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1097-103. PubMed ID: 27307725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases.
    Attaran D; Lari SM; Khajehdaluee M; Ayatollahi H; Towhidi M; Asnaashari A; Marallu HG; Mazloomi M; Mood MB
    Hum Exp Toxicol; 2009 Dec; 28(12):739-45. PubMed ID: 19919970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between serum uric acid and spirometric pulmonary function in Korean adults: The 2016 Korea National Health and Nutrition Examination Survey.
    Hong JW; Noh JH; Kim DJ
    PLoS One; 2020; 15(10):e0240987. PubMed ID: 33091060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
    Kjeldgaard P; Lykkegaard J; Spillemose H; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2323-2331. PubMed ID: 28831249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Raised CRP levels mark metabolic and functional impairment in advanced COPD.
    Broekhuizen R; Wouters EF; Creutzberg EC; Schols AM
    Thorax; 2006 Jan; 61(1):17-22. PubMed ID: 16055618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Airway regulatory T cells are decreased in COPD with a rapid decline in lung function.
    Eriksson Ström J; Pourazar J; Linder R; Blomberg A; Lindberg A; Bucht A; Behndig AF
    Respir Res; 2020 Dec; 21(1):330. PubMed ID: 33317530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Close Association between Subclinical Atherosclerosis and Pulmonary Function in Middle-Aged Male Smokers.
    Sugiura T; Dohi Y; Takagi Y; Yokochi T; Yoshikane N; Suzuki K; Tomiishi T; Nagami T; Iwase M; Takase H; Seo Y; Ohte N
    J Atheroscler Thromb; 2020 Nov; 27(11):1230-1242. PubMed ID: 32536635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD.
    Moy ML; Teylan M; Weston NA; Gagnon DR; Danilack VA; Garshick E
    Chest; 2014 Mar; 145(3):542-550. PubMed ID: 24091482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
    Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression.
    Halper-Stromberg E; Yun JH; Parker MM; Singer RT; Gaggar A; Silverman EK; Leach S; Bowler RP; Castaldi PJ
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):500-509. PubMed ID: 29206476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care.
    Schneider A; Dinant GJ; Maag I; Gantner L; Meyer JF; Szecsenyi J
    BMC Fam Pract; 2006 May; 7():28. PubMed ID: 16670014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.
    de Torres JP; Cordoba-Lanus E; López-Aguilar C; Muros de Fuentes M; Montejo de Garcini A; Aguirre-Jaime A; Celli BR; Casanova C
    Eur Respir J; 2006 May; 27(5):902-7. PubMed ID: 16455829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.